Epidermolysis bullosa simplex Advocacy Hub | UniteRare

At a Glance

Live from database

Regulatory Watchboard

1 event

Mar 2024A 44-week Monocentric Open Study Assessing the Efficacy and Safety of Deucravacitinib in Adults With Inflammatory Genodermatoses

Centre Hospitalier Universitaire de Nice — PHASE2

TrialRECRUITING

Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Financial Assistance

FINANCIAL LANDSCAPE SUMMARY

Total programs

No financial assistance programs currently listed for Epidermolysis bullosa simplex.
Check the disease page for updates →

Clinical Trial Landscape

1 active trial

1Phase 2

1Total recruiting

Search clinical trials for Epidermolysis bullosa simplex →

Recent News & Research

No recent news articles indexed yet for Epidermolysis bullosa simplex.
Search PubMed for Epidermolysis bullosa simplex →

Browse all Epidermolysis bullosa simplex news →

Specialist Network

Top 6 by expertise

Christine Chiaverini

Centre Hospitalier Universitaire de Nice

Score 261 trial15 pubs

Juliette Mazereeuw-hautier, MD

University Hospital of Toulouse

📍 Toulouse, Centre Hospitalier Universitaire de Toulouse

Score 73 trials

Bernard Cohen, MD

Professor of Dermatology

Score 51 trial

Mary Spellman, MD, M.D

Azitra Inc.

📍 SAN FRANCISCO, CA

Score 44 trials

Alexandra DJ Mancini, MSc, OTR/L

InMed Pharmaceuticals Inc.

📍 GREENACRES, FL

Score 41 trial

Carl Swartling

Uppsala University

Score 01 trial

View all Epidermolysis bullosa simplex specialists →

Quick Actions

📄

View Disease Page

Full profile, treatments, community

🔬

Search Clinical Trials

Find recruiting studies now

🩺

Find Specialists

Ranked by expertise & trials

💰

Financial Assistance

Copay cards, PAPs, grants

📰